Loading...
Back to narrative

Update shared on10 Sep 2025

Fair value Increased 6.88%
AnalystConsensusTarget's Fair Value
€45.50
4.6% overvalued intrinsic discount
10 Sep
€47.60
Loading
1Y
128.4%
7D
5.0%

Despite a reduction in consensus revenue growth forecasts, the valuation multiple for Exosens SAS has increased, driving the analyst price target up from €42.57 to €45.50.


What's in the News


  • Exosens announces a share repurchase program of up to 240,000 shares, intended to cover performance share plans for employees, with an expiration date of October 31, 2025.
  • The Board of Directors has authorized a buyback plan.
  • Exosens provides earnings guidance for full year 2025-2026, expecting revenue growth in the high teens.

Valuation Changes


Summary of Valuation Changes for Exosens SAS

  • The Consensus Analyst Price Target has risen from €42.57 to €45.50.
  • The Future P/E for Exosens SAS has risen from 24.29x to 26.34x.
  • The Consensus Revenue Growth forecasts for Exosens SAS has fallen from 13.4% per annum to 12.7% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.